The global Hypoglycemic Drugs Market is estimated to be valued at US$ 660 Mn in 2022 and is expected to exhibit a CAGR of 9.2% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The hypoglycemic drugs market refers to the pharmaceutical market dedicated to drugs and medications used to manage hypoglycemia or low blood sugar...